News and Trends 28 Sep 2022
Cleara Biotech closes $2.5M seed financing round to progress senescence treatment
…diseases in humans. Cleara Biotech is aiming to develop precision medicine tools that treat specific diseases with clear niche-directed, anti-senescent lead candidates, accompanied with associated biomarkers, around its FOXO4-based D-amino…